CORCEPT THERAPEUTICS INC (CORT) › Net IncomeCORCEPT THERAPEUTICS INC (CORT) — Net IncomeAnnual figures by fiscal year, from SEC filings.2000: -$1.85M2001: -$7.45M2002: -$18.50M2003: -$9.81M2004: -$15.54M2005: -$20.09M2006: -$24.87M2007: -$11.57M2008: -$20.06M2009: -$20.17M2010: -$25.97M2011: -$32.35M2012: -$38.05M2013: -$46.01M2014: -$31.38M2015: -$6.41M2016: $8.14M2017: $129.12M2018: $75.41M2019: $94.18M2020: $106.01M2021: $112.51M2022: $101.42M2023: $106.14M2024: $141.21M2025: $99.65M$99.65M2000Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$99.65M-29.4%2024$141.21M+33.0%2023$106.14M+4.7%2022$101.42M-9.9%2021$112.51M+6.1%2020$106.01M+12.6%2019$94.18M+24.9%2018$75.41M-41.6%2017$129.12M+1486.3%2016$8.14M+227.0%2015-$6.41M+79.6%2014-$31.38M+31.8%2013-$46.01M-20.9%2012-$38.05M-17.6%2011-$32.35M-24.6%2010-$25.97M-28.8%2009-$20.17M-0.5%2008-$20.06M-73.3%2007-$11.57M+53.5%2006-$24.87M-23.8%2005-$20.09M-29.3%2004-$15.54M-58.3%2003-$9.81M+47.0%2002-$18.50M-148.2%2001-$7.45M-303.8%2000-$1.85M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share